共 138 条
- [21] Morou S(2016)Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (treatment shortening of MDR-TB using existing and new drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial Adv Med Sci 61 63-undefined
- [22] Daouda M(2016)The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens Eur Respir J 47 564-undefined
- [23] Nunn AJ(2017)Pharmacological and molecular mechanisms behind the sterilizing activity of pyrazinamide Eur Respir J 49 1700387-undefined
- [24] Phillips PPJ(2020)Bactericidal and sterilizing activity of a novel regimen with Bedaquiline, Pretomanid, Moxifloxacin, and pyrazinamide in a murine model of tuberculosis Int J Infect Dis 96 68-undefined
- [25] Meredith SK(undefined)Pyrazinamide resistance in mycobacterium tuberculosis: review and update undefined undefined undefined-undefined
- [26] Chiang C-Y(undefined)Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis undefined undefined undefined-undefined
- [27] Conradie F(undefined)Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study undefined undefined undefined-undefined
- [28] Dalai D(undefined)Prediction of treatment outcomes for multidrug-resistant tuberculosis by whole-genome sequencing undefined undefined undefined-undefined
- [29] Conradie F(undefined)undefined undefined undefined undefined-undefined
- [30] Diacon AH(undefined)undefined undefined undefined undefined-undefined